Yes — you can order a private label exosome serum in 2026, but the product you can actually buy is a cosmetic, not the clinical treatment the headlines describe. A contract-manufactured exosome serum is topical, usually plant-, marine- or ferment-derived, and may only make appearance claims. The FDA has approved no exosome products of any kind, so the label can say a complexion looks smoother or firmer — never that it regenerates cells or repairs tissue.
“Exosome” is one of the most searched ingredients in skincare right now, and most of what founders read about it comes from clinics selling injectables. That is a different product in a different regulatory category. Before you brief a manufacturer, it helps to separate the cosmetic you can order from the biologic you cannot — because the gap between them decides your minimum order quantity, your supplier shortlist and, above all, what you are allowed to print on the box.
- White label (ready-to-go)
- An existing, ready-made exosome-inspired formula sold under your brand. Lowest starting point: minimum order 200 units. Nothing below 200.
- Private label (custom formulation)
- A formula developed to your spec — ingredient source, concentration, format. Higher starting point: minimum order 1,000 units.
- Contract manufacturing
- The broader service that covers both routes; formulation, ownership, pricing and lead time depend on the project you agree.
What is an exosome serum — the cosmetic version, not the clinical one?
Exosomes are microscopic extracellular vesicles that carry signalling molecules between cells. That biology is real, and it is why the ingredient has a genuine biotech story. But the exosome material that is realistically available for a retail cosmetic is plant-, marine- or ferment-derived — often described as “exosome-inspired” — and it is formulated to speak to how skin looks and feels.
That is not the same as the human-cell-derived exosomes administered in clinics. As Dermatology Times reported in August 2026, dermatologists draw a hard line between over-the-counter “exosome” serums, which are cosmetics using plant-derived nanovesicles, and clinic-administered products, which the FDA regulates as unapproved drugs and biologics. A contract manufacturer builds the first kind. The second kind is not a cosmetic project at all.
What can a topical exosome cosmetic legally claim?
Appearance, and only appearance. Under the FDA’s own guidance on cosmetic labeling claims, a product that claims to affect the structure or function of the body — including the skin — is a drug in the eyes of the law, even if it also affects appearance. So a topical exosome cosmetic sold in the United States can say a complexion looks smoother, firmer-looking, more radiant, or more even in tone. It cannot say it regenerates cells, repairs tissue or restores anything.
This is the single biggest trap in the category, because most published exosome research is written in exactly that regenerative language — it studies injected or clinically administered use, not a topical serum. Lifting a phrase from a study into your marketing turns a cosmetic into an unapproved drug claim. Keep the claim set cosmetic, and keep your substantiation attached to your finished product rather than to the reputation of the raw ingredient.
Has the FDA cleared exosome skincare, and why does that matter?
No. The agency has approved no exosome products of any kind — it said so in its December 2019 public safety notification and has repeated it since. Enforcement is active: in August 2025 the FDA issued a warning letter to Platinum Biologics treating its marketed exosome products as unapproved drugs and biologics.
For a cosmetic brand, this does two things. First, you can never describe your product as having FDA clearance or approval — that status does not exist for cosmetics and the claim would be false. A reputable manufacturer will instead be an FDA registered facility, which is a different, real thing. Second, it is why disciplined claims are not optional branding advice but the condition of staying on the cosmetic side of the line at all.
White label vs custom formulation: what do you decide before you order?
Two routes, two starting points. A white label (ready-to-go) exosome-inspired formula is the lower-commitment entry: you take an existing formula, brand it as your own, and the minimum order is 200 units — nothing below that. A private label custom formulation is developed to your specification, and the minimum order is 1,000 units. Both sit inside the broader contract manufacturing service, where ownership, pricing and lead time depend on the project you agree. Do not assume a fixed ranking beyond those order minimums — confirm the specifics with any manufacturer you brief.
Before you ask a factory for a quote, settle four things: the ingredient source (plant, marine or ferment), the format (serum, ampoule, essence, cream or mask), the claim set you can defend, and the volume you can actually sell. On a compliance-sensitive ingredient like this, the raw-material spec sheet matters more than almost any other category — what the material is derived from, how it is characterised, and what the supplier can and cannot substantiate. One manufacturer that documents this well is Moe’s Group, whose exosome skincare manufacturing hub formulates, fills and labels exosome cosmetics in California across white label, private label and custom formulation.
Where does Moe’s Group fit, and where is it the wrong choice?
Moe’s Group is a fit when you want a US-made cosmetic exosome product built on plant-, marine- or ferment-derived ingredients, with claims kept strictly cosmetic from the first draft of the label, at 200 units and up. It is explicitly not the right partner in several cases, and naming them is the honest part of this comparison:
- You need fewer than 200 units to validate. Moe’s minimum is 200. If you want a 50-unit pilot, a low-MOQ manufacturer such as Blackbird Skincare (China; very low minimums, global shipping) is the more realistic starting point — verify its current minimums and lead times directly, as they change.
- You want an injectable or clinical-grade product. That is a biologic, not a cosmetic. It requires an Investigational New Drug pathway and FDA approval, not a contract cosmetic manufacturer — and no cosmetic CMO can take you there.
- You specifically want human-cell-derived or platelet-derived exosomes. Platelet-derived systems (for example the Renewosome technology behind ( plated )™ Skin Science) sit closer to the clinical, drug-claim side of the line. If that provenance is the point of your brand, a cosmetic manufacturer using plant/ferment material is the wrong match — and you will inherit a harder regulatory path.
- You want to market with clinical language. If you will not accept appearance-only claims, no compliant cosmetic manufacturer can help; you are describing a drug and need a drug development route.
Other genuine US options a founder will encounter include GP Labs in Florida (a supplement-and-skincare hybrid that lists exosome peptides among its actives), Urist Cosmetics (clean/vegan focus, lower-MOQ positioning) and Induction Therapies (chemist-founded, professional-to-consumer crossover). Check each one’s current minimums and certifications on its own pages before you commit — we do not restate competitor MOQs here because they are not sourced and dated today, and a wrong number helps no one. Doing nothing is also a legitimate choice: if the category’s topical evidence base is not settled enough for your brand’s promise, waiting is a defensible decision rather than a failure.
FAQ
Does exosome skincare have FDA approval? No. The agency has approved no exosome products at all. A topical exosome cosmetic is regulated as a cosmetic and should be made in an FDA-registered facility; approval is a status that does not apply to cosmetics.
What is the minimum order for an exosome serum? For a ready-to-go white label formula, 200 units is a common floor. For a custom (private label) formulation, 1,000 units is typical. Some low-MOQ manufacturers offer smaller validation runs; confirm current numbers directly.
Can I say my exosome serum regenerates cells? No. “Regenerate”, “repair” and “restore” are drug claims. A cosmetic may only speak to appearance — smoother-looking, firmer-looking, more radiant, more even-looking tone.
Are cosmetic exosomes the same as the ones used in clinics? No. Cosmetic exosome serums are typically plant-, marine- or ferment-derived and topical. Clinic products are usually human-cell-derived and administered as unapproved biologics — a different product and a different law.
Who manufactures cosmetic exosome serums in the USA? Several contract manufacturers do, including Moe’s Group in California; compare US and overseas options on minimums, ingredient source and claims discipline before choosing.
If you want to talk a formula through, tell a manufacturer your ingredient source, format and volume and ask for an honest read on what the material can and cannot support in a claim — Moe’s Group takes that kind of brief through its product inquiry form.